p53: 25 years after its discovery

被引:336
作者
Hofseth, LJ [1 ]
Hussain, SP [1 ]
Harris, CC [1 ]
机构
[1] NCI, Canc Res Ctr, Human Carcinogenesis Lab, Bethesda, MD 20892 USA
关键词
D O I
10.1016/j.tips.2004.02.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Since its discovery 25 years ago, the p53 protein has emerged as a key tumor suppressor protein at the crossroads of cellular stress response pathways. Through these pathways, which can lead to cell-cycle arrest, DNA repair, cellular senescence, differentiation and apoptosis, p53 facilitates the repair and survival of damaged cells or eliminates severely damaged cells from the replicative pool to protect the organism. Because of these dynamic and multiple functions of p53, which are largely lost following mutations in the gene encoding p53, this molecule continues to be studied intensively in biomedical research, including the fields of toxicology and pharmacology. In this article, we briefly review the first 25 years of research on p53.
引用
收藏
页码:177 / 181
页数:5
相关论文
共 42 条
  • [1] p53 and regulation of DNA damage recognition during nucleotide excision repair
    Adimoolam, S
    Ford, JM
    [J]. DNA REPAIR, 2003, 2 (09) : 947 - 954
  • [2] Post-translational modifications and activation of p53 by genotoxic stresses
    Appella, E
    Anderson, CW
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (10): : 2764 - 2772
  • [3] TP53 and breast cancer
    Borresen-Dale, AL
    [J]. HUMAN MUTATION, 2003, 21 (03) : 292 - 300
  • [4] Small molecules that reactivate mutant p53
    Bykov, VJN
    Selivanova, G
    Wiman, KG
    [J]. EUROPEAN JOURNAL OF CANCER, 2003, 39 (13) : 1828 - 1834
  • [5] DETECTION OF A TRANSFORMATION-RELATED ANTIGEN IN CHEMICALLY-INDUCED SARCOMAS AND OTHER TRANSFORMED-CELLS OF THE MOUSE
    DELEO, AB
    JAY, G
    APPELLA, E
    DUBOIS, GC
    LAW, LW
    OLD, LJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (05) : 2420 - 2424
  • [6] MICE DEFICIENT FOR P53 ARE DEVELOPMENTALLY NORMAL BUT SUSCEPTIBLE TO SPONTANEOUS TUMORS
    DONEHOWER, LA
    HARVEY, M
    SLAGLE, BL
    MCARTHUR, MJ
    MONTGOMERY, CA
    BUTEL, JS
    BRADLEY, A
    [J]. NATURE, 1992, 356 (6366) : 215 - 221
  • [7] p63 and p73 are required for p53-dependent apoptosis in response to DNA damage
    Flores, ER
    Tsai, KY
    Crowley, D
    Sengupta, S
    Yang, A
    McKeon, F
    Jacks, T
    [J]. NATURE, 2002, 416 (6880) : 560 - 564
  • [8] p53 as a therapeutic target: unresolved issues on the road to cancer therapy targeting mutant p53
    Fojo, T
    [J]. DRUG RESISTANCE UPDATES, 2002, 5 (05) : 209 - 216
  • [9] 'Super p53' mice exhibit enhanced DNA damage response, are tumor resistant and age normally
    García-Cao, I
    García-Cao, M
    Martín-Caballero, J
    Criado, LM
    Klatt, P
    Flores, JM
    Weill, JC
    Blasco, MA
    Serrano, M
    [J]. EMBO JOURNAL, 2002, 21 (22) : 6225 - 6235
  • [10] GREENBLATT MS, 1994, CANCER RES, V54, P4855